Centro de Investigación en Ciencias Moleculares

UNIVERSITY STUDENTS RESEARCHING COQUI AND CORONAVIRUS 2 WIN GRANT TO GO TO WASHINGTON DC

Ariadna S. Rubio Lebrón's picture

Kellyann Román-Cruz and Héctor G. Torres-De Jesús were awarded scholarships to attend the Emerging Researchers National 2024 Conference, which will be held in Washington DC from March 14-16.

This opportunity will allow them not only to present the latest results of their scientific research conducted at the Center for Research in Molecular Sciences of the University of Puerto Rico (CICiM-UPR), but also to improve their scientific communication skills and explore global professional alternatives in the sciences, which are the main objectives of the conference.

ESTUDIANTES INVESTIGADORES DE “EL MOLECULAR” VIAJAN A PRESTIGIOSO LABORATORIO EN NUEVA YORK PARA HACER INVESTIGACIONES BIOMÉDICAS Y EN BATERÍAS

This article is reproduced by CienciaPR with permission from the original source.

CienciaPR Contribution: 

No

Alexis G. Lavín Flores, Keyla A. López Pérez and Nataniel Medina Berríos, all student researchers at the UPR Center for Research in Molecular Sciences (CICiM), under the mentorship of Dr. Gerardo Morell and Dr. Brad Weiner, traveled to the prestigious Brookhaven National Laboratory in Long Island, New York, as part of their graduate studies in chemistry.  

Tags: 

UNDER THE SLOGAN "ENVIRONMENTAL SUSTAINABILITY" THE MOLECULAR CENTER HELD AN OPEN HOUSE

This article is reproduced by CienciaPR with permission from the original source.

CienciaPR Contribution: 

No

In celebration of Bioscience, the Center for Research on Molecular Sciences (CICiM) recently held an Open House, under the theme of Environmental Sustainability.

Young people from high school to elementary school enjoyed VIP tours, interactive tables, a talk that integrated professors and student researchers on environmental issues, and the show 'The Magic of Chemistry'.

Tags: 

Efforts to develop a vaccine against HIV in Puerto Rico

Manuel Delgado-Vélez's picture

Even before its discovery in the mid-80s, the human immunodeficiency virus (HIV) was already responsible for one of the most devastating pandemics in the history of humankind. Since then there have been significant advances, ranging from the approval by the FDA ("Food and Drug Administration") of the first antiretroviral drug, zidovudine (AZT) in 19871; to the launch in 2015 by the World Health Organization (WHO) of the recommendation that all HIV-infected individuals should receive antiretroviral therapy immediately after being diagnosed.2  

First phase in HIV vaccine project is completed

This article is reproduced by CienciaPR with permission from the original source.

CienciaPR Contribution: 

No

By: 

Keila López Alicea

The University of Puerto Rico (UPR) is actively engaged in the race to develop a vaccine against HIV. In just 18 month, researchers from the Molecular Sciences Research Center at UPR have succesfully completed the first phase of a project to develop an HIV vaccine and are waiting for NIH aproval to begin the second phase. 

For the full article, please refer to the spanish version of this site. 

 

Tags: 

Subscribe to RSS - Centro de Investigación en Ciencias Moleculares